Deborah Lipstadt’s Foreword to ‘Unstoppable’ is More Relevant Than Ever Due to a Substantial Rise in Global Antisemitism

Unstoppable NEW YORK, May 17, 2022 (GLOBE NEWSWIRE) — US Special Envoy to Monitor and Combat Antisemitism, Deborah E. Lipstadt, explains in her Foreword to Joshua M. Greene’s Unstoppable: Siggi B. Wilzig’s Astonishing Journey from Auschwitz Survivor and Penniless Immigrant to Wall Street Legend why Siggi B. Wilzig’s life story is more relevant than ever. […]

Continue Reading

EV Technology Group Company, MOKE France, Announces Collaboration With SensCritique to Electrify the Croisette for the 2022 Cannes Film Festival

MOKE France and SensCritique partnering at the Cannes Film Festival TORONTO, May 17, 2022 (GLOBE NEWSWIRE) — EV Technology Group Ltd. (the “Company” or “EV Technology Group”) (NEO: EVTG, DE:B96A) announces today that its wholly owned subsidiary MOKE France SAS (“MOKE France”) will collaborate with film production company SensCritique, to electrify the Croisette at the […]

Continue Reading

RAJANT AND ACUBIS TECHNOLOGIES ANNOUNCE SUCCESSFUL FE1 PEREGRINE AND HAWK DEPLOYMENTS FOR STANWELL’S MEANDU MINE

100 BreadCrumbs deployed for CCTV, Access Control, Fleet Management and Autonomous Haulage Malvern, Pennsylvania (USA), May 17, 2022 (GLOBE NEWSWIRE) — Rajant Corporation, the pioneer of Kinetic Mesh® wireless networks, and Acubis Technologies, a Kinetic Mesh Premier Partner (KMPP) in Australia, have delivered the first FE1 series BreadCrumbs® – Rajant Peregrine and Hawk – to […]

Continue Reading

WHR Group, Inc. Named a Top Workplace for the Ninth Consecutive Year

MILWAUKEE, Wis., May 17, 2022 (GLOBE NEWSWIRE) — For the ninth consecutive year, WHR Group, Inc. (WHR) was named a Top Workplace by the Milwaukee Journal Sentinel. Top Workplaces surveys employee engagement and satisfaction at companies throughout the US. Awards are given to companies in different regions including the Northeast, Southeast, Midwest, Southwest, Rocky Mountains and […]

Continue Reading

Junshi Biosciences Receives NMPA Approval of sNDA for Toripalimab in Combination with Paclitaxel and Cisplatin in First-Line Treatment of Advanced or Distant Metastatic Esophageal Squamous Cell Carcinoma

–5th approved indication by NMPA significantly expands eligible patient population SHANGHAI, China, May 16, 2022 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced today that the China National Medical Products Administration (NMPA) has […]

Continue Reading